Insider · CIK 0001283535

PATOU GARY

Reports to the SEC for 3 companies · BURNABY

sec.gov

Transactions

Companies

Filings

CIK

0001283535

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−1,322 sh	$53.14	−$70.3K	24,896
2026-06-03	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,507
2026-06-03	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+1,593 sh	—	—	1,593
2026-06-01	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,645 sh	—	—	26,218
2026-06-01	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,645 sh	—	—	0
2025-06-05	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,012
2025-06-05	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+2,645 sh	—	—	2,645
2024-11-22	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,500 sh	$7.38	+$25.8K	27,073
2024-11-22	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−649 sh	$39.80	−$25.8K	26,424
2024-11-22	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,851 sh	$41.11	−$117K	23,573
2024-11-22	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$13.48	+$41.6K	26,659
2024-11-22	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−1,046 sh	$39.80	−$41.6K	25,613
2024-11-22	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,040 sh	$41.05	−$83.7K	23,573
2024-11-22	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,500 sh	—	—	0
2024-11-22	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2024-06-05	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,542
2023-12-14	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−7,598 sh	$41.05	−$312K	4,902
2023-12-13	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,378 sh	$9.85	+$62.8K	29,951
2023-12-13	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−1,278 sh	$39.68	−$50.7K	28,673
2023-12-13	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−5,100 sh	$38.94	−$199K	23,573
2023-12-13	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,880 sh	$9.85	+$28.4K	26,453
2023-12-13	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−577 sh	$39.68	−$22.9K	25,876
2023-12-13	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,303 sh	$39.10	−$90K	23,573
2023-12-13	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$9.00	+$46.3K	28,717
2023-12-13	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−1,167 sh	$39.68	−$46.3K	27,550
2023-12-13	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−3,977 sh	$39.84	−$158K	23,573
2023-12-13	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−7,598 sh	$41.05	−$312K	4,902
2023-12-13	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,378 sh	—	—	0
2023-12-13	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,800 sh	—	—	0
2023-12-13	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2023-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,475
2022-11-25	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$2.68	+$5,512.76	25,630
2022-11-25	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−120 sh	$34.37	−$4,124.4	25,510
2022-11-25	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−1,937 sh	$34.79	−$67.4K	23,573
2022-11-25	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2022-11-23	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,057 sh	$34.33	−$70.6K	23,573
2022-06-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-12-08	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.67	+$7,549.19	25,630
2021-12-08	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2021-06-03	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-03-17	XENEXenon Pharmaceuticals Inc.L Small Acquisition	Director	LSmall Acquisition	+100 sh	$19.49	+$1,949	100
2020-10-28	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.76	+$7,734.32	23,573
2020-10-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2020-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-12-04	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.56	+$7,322.92	21,516
2019-12-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2019-09-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-12-14	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.07	+$6,314.99	19,459
2018-12-14	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2018-06-14	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,230 sh	$3.70	+$30.5K	20,258

Recent filings

Accepted (ET)
Jun 84
PATOU GARY0001193125-26-262672
SEC(opens sec.gov)
Jun 34
PATOU GARY0001193125-26-256126
SEC(opens sec.gov)
Jun 64
PATOU GARY0000950170-25-083329
SEC(opens sec.gov)
Nov 224
PATOU GARY0000950170-24-130378
SEC(opens sec.gov)
Jun 54
PATOU GARY0000950170-24-069468
SEC(opens sec.gov)
Dec 154
PATOU GARY0000950170-23-070841
SEC(opens sec.gov)

Companies

Address

3650 GILMORE WAY

BURNABY, V5G 4W8